The protection against Cu stress by standard Wilson disease therapeutics, i.e., D-Pen, trientine, and TTM, has been assessed on the parental HepG2/C3a cell line and two complete atp7b KO cell lines, sg1-1 and sg2-1. This evidence concerns the gene SLITRK1 and Wilson disease.